Hims & Hers Stock Missed Estimates Last Quarter — Can It Turn the Page Tonight?

Hims & Hers Health Inc. (NYSE: HIMS ) shares are in the spotlight Monday ahead of the company’s second-quarter earnings report today after the market closes.

Hims & Hers Health shares are under pressure.

Why is HIMS stock retreating? Earnings Preview & History Hims & Hers is expected to report a loss of 1 cent per share along with revenue of $699.89 million.

For the prior quarter, the company reported a loss of 40 cents per share, missing the consensus estimate of 4 cents per share.

Revenue came in at $608.10 million, missing the consensus estimate of $616.85 million.

What to Watch: Subscriber Growth, Revenue Per User in Focus Investors will be closely tracking subscriber growth and revenue per subscriber, given management’s full-year 2026 guidance calling for revenue of $2.8 billion to $3.0 billion and adjusted EBITDA of $275 million to $350 million.

Commentary on the company’s weight loss and personalized treatment offerings will also be in focus, along with any updates on regulatory scrutiny surrounding compounded GLP-1 medications.

Progress toward management’s 2030 targets of at least $6.5 billion in revenue and $1.3 billion in adjusted EBITDA should offer additional signals on the durability of the company’s long-term growth story.

Squeezed Between a Cluster of Moving Averages Hims and Hers is sitting in a tight technical zone: at $31.06, it’s essentially flat versus the 20-day EMA ($31.08) and just under the 20-day SMA ($31.19), while also pressing up toward the 50-day SMA ($31.57).

That "cluster" of nearby averages often acts like a magnet, and a clean push back above the 50-day area can improve the near-term trend picture.

Momentum is neutral, with RSI at 51.65—meaning the stock isn’t stretched to an overbought or oversold extreme and can still break either direction if price clears a key level.

Zooming out, the stock remains above its longer-term baselines (about 13.6% above the 100-day SMA at $27.91 and about 6.9% above the 200-day SMA at $29.64), but the 20-day SMA still being below the 50-day SMA keeps the short-term trend from fully turning higher.

Key Resistance: $36.00 — a round-number area that can cap rebounds if the stock can’t build acceptance above the low-$30s Key Support: $30.00 — a nearby round-number floor that lines up with the current "battle zone" around the 200-day trend area Read Also: Stock Market Today: Dow, S&P 500 Futures Fell as Trump Says US Is 'Only Semi-Negotiating' With Iran—T.

Rowe, Plug Power, BIO-Key in Focus (UPDATED) Hims And Hers Share Price Activity HIMS Price Action: At the time of publication, Hims & Hers stock is trading 0.95% lower at $31.29, according to data Pro.

This illustration was generated using artificial intelligence via Midjourney.